Published on
April 2, 2025
- 05:53 GMT
Nonprofit-led gene therapy breaks through with EU backing, changing the rare disease model
Gene therapy for CTNNB1 Syndrome advances to trials with EU recognition, preclinical success, and political support for affordable public access. LJULJANA, SLOVENIA, April 2, 2025 /EINPresswire.com/ -- In a move that could reshape how advanced therapies …
Distribution channels:
Business & Economy, Healthcare & Pharmaceuticals Industry
...
